Bromodeoxyuridine

A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.

Also Known As:

BrdU; Broxuridine; 5 Bromodeoxyuridine; 5-Bromo-2'-deoxyuridine; 5-Bromodeoxyuridine; NSC-38297; 5 Bromo 2' deoxyuridine; Deoxyriboside, Bromouracil; BUdR; Bromouracil Deoxyriboside; Uridine, 5-bromo-2'-deoxy-

Pharmalogical Action Categories:

Antimetabolites
Antimetabolites, Antineoplastic
Antiviral Agents
Radiation-Sensitizing Agents

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidine Nucleosides: 50
      - Uridine: 1186
        Deoxyuridine: 331
        Bromodeoxyuridine: 3535
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Uridine: 1186
      - Deoxyuridine: 331
        Bromodeoxyuridine: 3535
  - Deoxyribonucleosides: 34
    - Deoxyuridine: 331
      - Bromodeoxyuridine: 3535

Akihiko Hirayama Selected Research

Akihiko Hirayama Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure